Price Target Changed • Jun 08
Price target decreased by 9.0% to CN¥30.57 Down from CN¥33.59, the current price target is an average from 6 analysts. New target price is 37% above last closing price of CN¥22.28. Stock is down 51% over the past year. The company is forecast to post earnings per share of CN¥0.83 for next year compared to CN¥0.62 last year. New Risk • May 01
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. Payout ratio: 94% Cash payout ratio: 160% Dividend yield: 2.0% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 94% Cash payout ratio: 160% Minor Risk Profit margins are more than 30% lower than last year (6.1% net profit margin). Announcement • Apr 30
Guangdong Marubi Biotechnology Co., Ltd., Annual General Meeting, May 25, 2026 Guangdong Marubi Biotechnology Co., Ltd., Annual General Meeting, May 25, 2026, at 14:30 China Standard Time. Location: 11F, No. 69, Xingang East Road, Haizhu District, Guangzhou, Guangdong China